It is a pharma private limited company based in Kalpetta, Kerala, India, established in 2001.
2001 | Kalpetta, Kerala, India | ActiveWhite Line Pharma Private Limited, a active private limited company, was established on 21 December 2001 in Kalpetta, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231KL2001PTC015134. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.
It upholds a compliant status. Its leadership includes Kizhakke Puthankandi Muhammad Sharmil (Director), Aramangalam Krishnan Chetty Ramakrishnan (Managing Director), Cholangady Kalappan Vinod (Director). Past directors included Kunhimoideen. It holds ₹3.64 Cr open charges and ₹3.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No.Xiii/897(3), Sakthi Arcade Leo Hospital Road,Vythiri Taluk, Kalpetta, Kerala, 673121.
U24231KL2001PTC015134
015134
21 December 2001
₹7.50 M
₹7.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into White Line Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kizhakke Puthankandi Muhammad Sharmil | Director | 31 Dec 2019 | Current |
| Aramangalam Krishnan Chetty Ramakrishnan | Managing Director | 21 Dec 2001 | Current |
| Cholangady Kalappan Vinod | Director | 21 Dec 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Oct 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
White Line Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.82% increase. The company also saw a substantial improvement in profitability, with a 41.88% increase in profit. The company's net worth moved up by a moderate rise of 9.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, White Line Pharma had a public holding of 84.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹36,368,000.00
₹39,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2022 | Others | ₹2.10 M | Open |
| 10 Jun 2020 | Others | ₹4.27 M | Open |
| 02 Aug 2017 | Others | ₹3.00 Cr | Open |
| 13 Mar 2013 | State Bank Of Travancore | ₹1.95 Cr | Satisfied |
| 17 May 2012 | Vijaya Bank | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with White Line Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of White Line Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White Line Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
White Line Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on White Line Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on A charge with Others of Rs. 30.00 M registered on 02 Aug 2017 with Charge ID 100120512 was modified on 18 Mar 2023. was documented.
The activity A charge with Others amounted to Rs. 2.10 M with Charge ID 100530163 was registered on 24 Jan 2022. was completed.
Progress on A charge with Others amounted to Rs. 4.27 M with Charge ID 100345305 was registered on 10 Jun 2020. was documented.
Progress on Kizhakke Puthankandi Muhammad Sharmil was appointed as a Director was appointed as a Director on 31 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
The CIN of White Line Pharma Private Limited is U24231KL2001PTC015134.
White Line Pharma Private Limited is headquartered at Door No.Xiii/897(3), Sakthi Arcade Leo Hospital Road,Vythiri Taluk, Kalpetta, Kerala, 673121.
White Line Pharma Private Limited was incorporated on 21 December 2001.
The current directors of White Line Pharma Private Limited are
The primary industry of White Line Pharma Private Limited is Trade.
White Line Pharma Private Limited is unlisted.
The authorized capital of White Line Pharma Private Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.
The compliance status of White Line Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX